ACRS
NASDAQ · Pharmaceuticals
Aclaris Therapeutics Inc
$3.69
-0.05 (-1.34%)
Open$3.76
Previous Close$3.74
Day High$3.78
Day Low$3.60
52W High$4.89
52W Low$1.05
Volume—
Avg Volume3.46M
Market Cap445.00M
P/E Ratio—
EPS$-0.53
SectorPharmaceuticals
Analyst Ratings
Strong Buy
14 analysts
Price Target
+382.1% upside
Current
$3.69
$3.69
Target
$17.79
$17.79
$13.99
$17.79 avg
$22.90
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 7.60M | 11.87M | 98.24M |
| Net Income | -63,025,271 | -88,532,454 | 16.97M |
| Profit Margin | -829.6% | -788.1% | 17.3% |
| EBITDA | -69,997,672 | -103,789,274 | 25.23M |
| Free Cash Flow | — | — | 16.84M |
| Rev Growth | -35.9% | -35.9% | +7.1% |
| Debt/Equity | — | — | 1.07 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $916.31 | +1.47% | 46.4 | 957.52B |
| JNJ | Johnson & Johnson | $239.93 | +1.98% | 22.2 | 594.00B |
| MRK | Merck & Co. Inc. | $119.37 | +2.58% | 16.5 | 301.17B |
| PFE | Pfizer Inc. | $27.28 | +1.19% | 19.7 | 153.36B |
| BMY | Bristol-Myers Squibb Co | $58.94 | +2.70% | 16.5 | 116.58B |
| ZTS | Zoetis Inc | $116.71 | +0.67% | 21.5 | 57.37B |